So the book that I wrote, I mainly wrote the book for consumers, right
A separate Phase 2 trial also published in The New England Journal of Medicine in 2023 evaluated retatrutide in adults with type 2 diabetes, reporting meaningful reductions in HbA1c alongside weight loss, with hypoglycaemia rates that were low in the absence of insulin or sulfonylurea co-administration
Compounded semaglutide uses the same active ingredient but may differ in formulation, concentration, and added compounds
Research indicates it may support collagen cross-linking and stabilization through its role as a cofactor in hydroxylation reactions
Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS et al
You may qualify if your BMI is 27 or higher with weight-related health factors, or 30 or higher without